Similarly, in a malaria vaccine model, a heterologous Ad prime followed by an MVA boost induced not only higher frequencies of CD8+ T cells but also more durable and polyfunctional responses, surpassing those generated by both Ad–Ad and heterologous Ad–Ad combinations (25, 71). The gene discussed is CD8A; the disease is malaria.